Health & Biotech

CMEF 2026 Shanghai to Spotlight AI, Robotics and Global Medical Tech Innovation

From AI diagnostics to exoskeletons, the event highlights how healthcare tech is moving into real-world use

Updated

April 8, 2026 10:43 AM

Tesla Bot Optimus, designed by Tesla. PHOTO: ADOBE STOCK

The China International Medical Equipment Fair 2026 will open in Shanghai from April 9 to 12 at the National Exhibition and Convention Center. It is one of the largest gatherings in the medical device industry. This year’s edition will cover more than 320,000 square metres. Nearly 5,000 companies and brands are expected to participate, representing over 20 countries and regions. Organisers also expect more than 200,000 professional visitors and buyers from around 150 markets.

A key focus this year is the growing use of artificial intelligence in healthcare. One of the headline technologies is an AI agent designed to carry out multiple diagnoses from a single scan. The exhibition will also feature diagnostic software that is already in clinical use. In addition, an integrated platform for AI training and inference will be showcased to improve computing capacity within healthcare institutions.

Robotics will also play a central role at the event. New systems across surgical procedures, rehabilitation and elderly care are expected to be presented. Together, these developments point to a steady move toward more precise and assisted forms of care. Many of these technologies are designed to support clinicians and patients, especially in tasks that require consistent accuracy or long-term physical assistance.

For the first time, the event will introduce a dedicated Future Tech Arena. It will focus on brain-computer interfaces, embodied intelligence and university-led innovation. The space will include AI-assisted MRI systems for Alzheimer’s diagnosis. It will also feature brain-computer interface technologies used for cognitive assessment and training, along with wearable robotic exoskeletons.

Alongside product showcases, the event will continue to act as a platform for international trade and collaboration. An International Zone will host exhibitors from countries such as the United States, Germany, Japan, South Korea, the United Kingdom, France, Singapore, Malaysia and Thailand. This provides a view of how different markets are approaching medical technology. It also reflects the global nature of innovation and deployment in this sector.

The programme will include a set of networking and exchange formats under its “We” initiative. These include discussion stages with representatives from consulates and industry organisations, as well as matchmaking sessions based on verified buyer demand. Guided tours will also be organised to help international visitors connect with relevant exhibitors. In parallel, organisers are working with hospital partners to provide medical support services for attendees during the event.

Across the four days, hundreds of forums are scheduled. These will bring together policymakers, researchers and industry leaders to discuss regulatory frameworks, market access and the future of healthcare innovation. Some of these sessions will be led by the Global Harmonization Working Party in collaboration with the Ministry of Health of Malaysia, with a focus on regulatory alignment and cross-border cooperation in medical devices.

As healthcare systems continue to adopt digital tools and advanced equipment, events like CMEF provide a clear view of how these technologies are being developed and applied. The scale of participation this year reflects continued activity across both innovation and international collaboration in the medical device sector.

Keep Reading

Artificial Intelligence

How AI Is Reinventing Speech Therapy for Children

Clinically grounded, game-based and always available — MIRDC’s AI system is redefining how children learn to communicate.

Updated

January 8, 2026 6:32 PM

A child practicing with a speech therapist. PHOTO: FREEPIK

Speech and language delays are common, yet access to therapy remains limited. In Taiwan, only about 2,200 licensed speech-language pathologists serve hundreds of thousands of children who need support—especially those with autism spectrum disorders or significant communication challenges. As a result, many children miss crucial periods of language development simply because help isn’t available soon enough.

MIRDC’s new AI-powered interactive speech therapy system aims to close that gap. Instead of focusing solely on articulation, it targets a wider range of language skills that many children struggle with: oral expression, comprehension, sentence building and conversational ability. This makes it a more complete tool for childhood speech and language development.

The system combines game-based learning, AI-driven guidance and automated language assessment into one platform that can be used both in clinics and at home. This integrated design helps children practice more consistently, providing therapists and parents with clearer insight into their progress.

The interactive game modules are built around clinically validated therapy methods. Imitation exercises, picture cards, storybooks and conversational prompts are turned into structured game levels, each aligned with a specific developmental goal. This step-by-step approach helps children move from simple naming tasks to more complex comprehension and response skills, all within a sequenced curriculum.

A key differentiator is the system’s real-time AI speech interpretation. As the child talks, the AI analyzes the response and generates tailored therapeutic cues—such as imitation, modeling, expansion or extension—based on the conversation. These are the same strategies used by speech-language pathologists, but now children can access them continuously, supporting more effective at-home practice and reducing long gaps between sessions.

After each session, the system automatically conducts a data-driven language assessment using 20 objective indicators across semantics, syntax and pragmatics. This provides clinicians and families with measurable, easy-to-understand reports that show how the child is progressing and which skills need more attention—something many traditional tools do not offer.

By offering a personalized, scalable and clinically grounded solution, MIRDC’s AI therapy system helps address the ongoing shortage of speech-language services. It doesn’t replace therapists; instead, it extends their reach, allows for more consistent practice and helps families support their child’s communication at home.

As an added recognition of its impact, the system recently earned two R&D 100 Awards, including the Silver Award for Corporate Social Responsibility. But at its core, the project remains focused on a simple mission: making high-quality speech therapy accessible to every child who needs a voice.